SERA
Sera Prognostics, Inc.NASDAQHealthcare$2.01-2.90%ClosedMarket Cap: $76.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.52
P/S
1084.01
EV/EBITDA
-2.42
DCF Value
$-0.01
FCF Yield
-30.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-102.5%
Operating Margin
-45066.7%
Net Margin
-39417.3%
ROE
-37.5%
ROA
-31.3%
ROIC
-47.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $10.0K | -320.0% | $-9.0M | $-7.9M | $-0.16 | — |
| FY 2025 | $81.0K | -102.5% | $-36.5M | $-31.9M | $-0.67 | — |
| Q3 2025 | $16.0K | -156.3% | $-9.0M | $-7.8M | $-0.16 | — |
| Q2 2025 | $17.0K | -141.2% | $-9.3M | $-8.0M | $-0.16 | — |
| Q1 2025 | $38.0K | -5.3% | $-9.3M | $-8.2M | $-0.20 | — |
| Q4 2024 | $24.0K | -33.3% | $-9.4M | $-8.6M | $-0.25 | — |
| FY 2024 | $77.0K | -6.5% | $-36.6M | $-32.9M | $-0.99 | — |
| Q3 2024 | $29.0K | 55.2% | $-8.9M | $-7.9M | $-0.24 | — |
| Q2 2024 | $24.0K | 16.7% | $-9.3M | $-8.3M | $-0.25 | — |
| Q1 2024 | $0.00 | -Infinity% | $-9.1M | $-8.1M | $-0.25 | — |
| Q4 2023 | $41.0K | -475.6% | $-8.7M | $-7.9M | $-0.25 | — |
| FY 2023 | $306.0K | 31.4% | $-39.8M | $-36.2M | $-1.16 | — |